OUR EVOLUTION
Over the last 2 decades, we have grown from a single manufacturing facility focused on the Indian market to four locations producing scores of products, approvals from multiple regulators and a global reach.
-
2001
- Glenmark Pharmaceuticals established its API business *
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2002
- Established manufacturing plant at Kurkumbh, Maharashtra*
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2003
- First product registered with US FDA*
- Acquired Glaxo SmithKline’s (GSK) API manufacturing plant in Ankleshwar, Gujarat *
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2004
- Commenced manufacturing at Mohol, Maharashtra*
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2008
- Ankleshwar plant at Gujarat inspected by US FDA*
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2012
- Ankleshwar plant inspected by PMDA and AFSSAPS
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2013
- Commenced manufacturing at Dahej, Gujarat*
- Ankleshwar plant inspected by COFEPRIS*
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2015
- Dahej plant inspected by US FDA
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2016
- Dahej plant inspected by PMDA Japan
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2018
- Dahej plant inspected by EDQM, ANSM and US FDA*
- Mohol plant inspected by US FDA*
*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.
-
2019
- The API business was spun off into Glenmark Life Sciences
- Ankleshwar plant inspected by US FDA, Health Canada and PMDA, Japan
-
2021
- Achieved milestone of 403 cumulative drug master files (DMFs) across multiple markets globally
- Gets listed on Indian Stock Exchanges
-
2022
- Dahej Manufacturing facility gets ANVISA GMP certified
